ar 12463 has been researched along with thromboxanes in 3 studies
| Studies (ar 12463) | Trials (ar 12463) | Recent Studies (post-2010) (ar 12463) | Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 3,202 | 149 | 199 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Block, HU; Gabbasov, ZA; Mest, HJ; Popov, EG; Pozin, EY | 1 |
| Block, HU; Dunemann, A; Mest, HJ; Niebisch, M | 1 |
| Mest, HJ; Steinborn, C; Taube, C | 1 |
3 other study(ies) available for ar 12463 and thromboxanes
| Article | Year |
|---|---|
Inhibition of cytosolic Ca++ mobilization in human platelets by the antianginal drug trapidil and its derivative AR 12463.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Antihypertensive Agents; Blood Platelets; Calcium; Cytosol; Humans; In Vitro Techniques; Kinetics; Phosphoric Diester Hydrolases; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyrimidines; Thromboxanes; Trapidil | 1988 |
Influence of the antianginal drug trapidil and its derivative AR 12463 on arachidonic acid liberation and thromboxane formation in thrombin-stimulated platelets.
Topics: Antihypertensive Agents; Arachidonic Acids; Blood Platelets; Humans; In Vitro Techniques; Kinetics; Pyrimidines; Thrombin; Thromboxanes; Trapidil | 1988 |
Trapidil derivative AR 12463 lowers blood pressure and thromboxane formation in spontaneously hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Male; Muscle, Smooth, Vascular; Pyrimidines; Rats; Rats, Inbred SHR; Thromboxanes; Trapidil | 1987 |